The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Multitargeted therapy of cancer by silymarin
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Tyagi, A., Agarwal, C., Harrison, G. S., Glode, L. M., & Agarwal, R. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh180 · Cited by 149
Self-citationRetractedTyagi, A., Singh, R. P., Agarwal, C., & Agarwal, R. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl098 · Cited by 76
Self-citationRetractedA phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients
Flaig, T. W., Gustafson, D. L., Su, L.-J., Zirrolli, J. A., Crighton, F., Harrison, G. S., Pierson, A. S., Agarwal, R., & Glodé, L. M. (2007) · Investigational New Drugs · doi:10.1007/s10637-006-9019-2 · Cited by 315
Self-citationAnticancer potential of silymarin: from bench to bed side.
Agarwal, R., Agarwal, C., Ichikawa, H., Singh, R. P., & Aggarwal, B. B. (2006) · PubMed · Cited by 299
Self-citationSilymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis.
Manna, S. K., Mukhopadhyay, A., Van, N. T., & Aggarwal, B. B. (1999) · PubMed · Cited by 293
Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system
Wu, W., Wang, Y., & Que, L. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.12.005 · Cited by 291
Silymarin Suppresses TNF-Induced Activation of NF-κB, c-Jun N-Terminal Kinase, and Apoptosis
Manna, S. K., Mukhopadhyay, A., Van, N. T., & Aggarwal, B. B. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.12.6800 · Cited by 273
Milk Thistle Nomenclature: Why It Matters in Cancer Research and Pharmacokinetic Studies
Kroll, D. J., Shaw, H. S., & Oberlies, N. H. (2007) · Integrative Cancer Therapies · doi:10.1177/1534735407301825 · Cited by 268
Kidd, P. M., & Head, K. A. (2005) · PubMed · Cited by 253
Volate, S. R., Davenport, D. M., Muga, S. J., & Wargovich, M. J. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi089 · Cited by 253
Lee, D. Y.-W., & Liu (2003) · Journal of Natural Products · doi:10.1021/np030163b · Cited by 242
Barzaghi, N., Crema, F., Gatti, G., Pifferi, G., & Perucca, E. (1990) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03190223 · Cited by 226
Davis-Searles, P. R., Nakanishi, Y., Kim, N.-C., Graf, T. N., Oberlies, N. H., Wani, M. C., Wall, M. E., Agarwal, R., & Kroll, D. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4662 · Cited by 218
Self-citationAdvances in the Use of Milk Thistle (Silybum marianum)
Post-White, J., Ladas, E. J., & Kelly, K. M. (2007) · Integrative Cancer Therapies · doi:10.1177/1534735407301632 · Cited by 176
Chu, S., Chiou, H., Chen, P., Yang, S., & Hsieh, Y. (2004) · Molecular Carcinogenesis · doi:10.1002/mc.20018 · Cited by 176
Zi, X., Grasso, A. W., Kung, H.-J., & Agarwal, R. (1998) · PubMed · Cited by 167
Self-citationHoh, C., Boocock, D., Marczylo, T., Singh, R., Berry, D. P., Dennison, A. R., Hemingway, D., Miller, A., West, K., Euden, S., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2724 · Cited by 166
Effect of Silibinin on the Growth and Progression of Primary Lung Tumors in Mice
Singh, R. P., Deep, G., Chittezhath, M., Kaur, M., Dwyer-Nield, L. D., Malkinson, A. M., & Agarwal, R. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj231 · Cited by 165
Self-citationZi, X., Feyes, D. K., & Agarwal, R. (1998) · PubMed · Cited by 164
Self-citationOxidised derivatives of silybin and their antiradical and antioxidant activity
Gažák, R., Svobodová, A. R., Psotová, J., Sedmera, P., Přikrylová, V., Daniela Walterová, B., & Křen, V. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.07.064 · Cited by 156
Kohno, H., Tanaka, T., Kawabata, K., Hirose, Y., Sugie, S., Tsuda, H., & Mori, H. (2002) · International Journal of Cancer · doi:10.1002/ijc.10625 · Cited by 149
Gu, M., Singh, R. P., Dhanalakshmi, S., Agarwal, C., & Agarwal, R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3955 · Cited by 149
Self-citationProstate cancer chemoprevention by silibinin: Bench to bedside
Singh, R. P., & Agarwal, R. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20223 · Cited by 147
Self-citationSingh, R. P., Gu, M., Sharma, G. D., Dhanalakshmi, S., Tyagi, A. K., Chan, D. C. F., Agarwal, C., & Agarwal, R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1435 · Cited by 131
Self-citationJiang, C., Agarwal, R., & Lü, J. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3474 · Cited by 128
Self-citationChemopreventive Efficacy of Silymarin in Skin and Prostate Cancer
Deep, G., & Agarwal, R. (2007) · Integrative Cancer Therapies · doi:10.1177/1534735407301441 · Cited by 128
Self-citationSchröder, F. H., Roobol, M. J., Boevé, E. R., de Mutsert, R., Leeuwen, S. D. Z.-V., Kersten, I., Wildhagen, M. F., & van Helvoort, A. (2005) · European Urology · doi:10.1016/j.eururo.2005.08.005 · Cited by 127
Hsieh, Y., Chu, S., Yang, S., Chen, P.-N., Liu, Y.-C., & Lu, K. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl221 · Cited by 121
PRASAIN, J. K., & Barnes, S. (2007) · Molecular Pharmaceutics · doi:10.1021/mp700116u · Cited by 114
Silibinin Inhibits Invasion of Oral Cancer Cells by Suppressing the MAPK Pathway
Chen, P.-N., Hsieh, Y., Chiang, C.-L., Chiou, H. L., Yang, S., & Chu, S. (2006) · Journal of Dental Research · doi:10.1177/154405910608500303 · Cited by 113
Effects and mechanisms of silibinin on human hepatoma cell lines
Lah, J. J., Cui, W., & Hu, K.-Q. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i40.5299 · Cited by 105
Attenuation of UVA-induced damage to human keratinocytes by silymarin
Svobodová, A. R., Zdařilová, A., Mališková, J., Mikulková, H., Walterová, D., & Vostálová, J. (2007) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2006.12.009 · Cited by 104
Scambia, G., Vincenzo, R. D., Ranelletti, P. O., Panici, P. B., Ferrandina, G., D’Agostino, G. R., Fattorossi, A., Bombardelli, E., & Mancuso, S. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00011-1 · Cited by 103
Matsuda, T., Ferreri, K., Todorov, I., Kuroda, Y., Smith, C. V., KANDEEL, F. R., & Mullen, Y. (2004) · Endocrinology · doi:10.1210/en.2004-0850 · Cited by 102
Anti-angiogenic effect of silymarin on colon cancer lovo cell line
Yang, S.-H., Lin, J.-K., Chen, W.-S., & Chiu, J. (2003) · Journal of Surgical Research · doi:10.1016/s0022-4804(03)00229-4 · Cited by 99
Singh, R. P., Tyagi, A., Sharma, G. D., Mohan, S., & Agarwal, R. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1565 · Cited by 97
Self-citationAgarwal, R., Katiyar, S. K., Lundgren, D. W., & Mukhtar, H. (1994) · Carcinogenesis · doi:10.1093/carcin/15.6.1099 · Cited by 97
Self-citationClinical Applications of Silybum marianum in Oncology
Greenlee, H., Abascal, K., Yarnell, E. L., & Ladas, E. J. (2007) · Integrative Cancer Therapies · doi:10.1177/1534735407301727 · Cited by 95
Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cells
Tyagi, A., Bhatia, N., Condon, M. S., Bosland, M. C., Agarwal, C., & Agarwal, R. (2002) · The Prostate · doi:10.1002/pros.10146 · Cited by 89
Self-citationKiruthiga, P. V., Shafreen, R. B., Pandian, S. K., & Devi, K. P. (2007) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2007.00069.x · Cited by 82
Antifibrotic effects of tetrandrine on hepatic stellate cells and rats with liver fibrosis
Hsu, Y., Chiu, Y., Cheng, C., Wu, C., Lin, Y., & Huang, Y. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04361.x · Cited by 82
Deep, G., Oberlies, N. H., Kroll, D. J., & Agarwal, R. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm069 · Cited by 82
Self-citationGallo, D., Giacomelli, S., Ferlini, C., Raspaglio, G., Apollonio, P., Prislei, S., Riva, A., Morazzoni, P., Bombardelli, E., & Scambia, G. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00624-5 · Cited by 80
Džubák, P., Hajdúch, M., Gažák, R., Svobodová, A. R., Psotová, J., Walterová, D., Sedmera, P., & Křen, V. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.01.035 · Cited by 78
Singh, R. P., & Agarwal, R. (2004) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.05.017 · Cited by 78
Self-citationRaina, K., Blouin, M., Singh, R. P., Majeed, N., Deep, G., Varghese, L., Glodé, L. M., Greenberg, N. M., Hwang, D., Cohen, P., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2222 · Cited by 75
Self-citationFlaig, T., Su, L.-J., Harrison, G., Agarwal, R., & Glodé, L. (2007) · International Journal of Cancer · doi:10.1002/ijc.22465 · Cited by 72
Self-citationTyagi, A., Raina, K., Singh, R. P., Gu, M., Agarwal, C., Harrison, G. S., Glodé, L. M., & Agarwal, R. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2006 · Cited by 63
Self-citationProvinciali, M., Papalini, F., Orlando, F., Pierpaoli, S., Donnini, A., Morazzoni, P., Riva, A., & Smorlesi, A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2601 · Cited by 57
Comparative bioavailability of silibinin in healthy male volunteers
Kim, Y. C., Kim, E. J., Lee, E. D., Kim, J. H., Jang, S. W., Kim, Y. G., Kwon, J.-T., Kim, W. B., & Lee, M. (2003) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp41593 · Cited by 56
Vinh, P. Q., Sugie, S., Tanaka, T., Hara, A., Yamada, Y., Katayama, M., Deguchi, T., & Mori, H. (2002) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2002.tb01199.x · Cited by 55
Yanaida, Y. (2002) · Carcinogenesis · doi:10.1093/carcin/23.5.787 · Cited by 51
Enhancement of mammary carcinogenesis in two rodent models by silymarin dietary supplements
Malewicz, B. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl032 · Cited by 46
Kohno, H., Suzuki, R., Sugie, S., Tsuda, H., & Tanaka, T. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0137 · Cited by 37
Li, L.-H., Wu, L.-J., Tashiro, S., Onodera, S., Uchiumi, F., & Ikejima, T. (2007) · Journal of Asian Natural Products Research · doi:10.1080/10286020600604260 · Cited by 31
Varga, Z., Újhelyi, L., Kiss, A., Balla, J., Czompa, A., & Antus, S. (2004) · Phytomedicine · doi:10.1078/0944-7113-00358 · Cited by 23
Cited by
Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives
Surai, P. (2015) · Antioxidants · doi:10.3390/antiox4010204 · Cited by 738
Plant-derived anticancer agents: A green anticancer approach
Iqbal, J., Abbasi, B. A., Mahmood, T., Kanwal, S., Ali, B., Shah, S. A., & Khalil, A. T. (2017) · Asian Pacific Journal of Tropical Biomedicine · doi:10.1016/j.apjtb.2017.10.016 · Cited by 685
Milk thistle in liver diseases: past, present, future
Abenavoli, L., Capasso, R., Milic, N., & Capasso, F. (2010) · Phytotherapy Research · doi:10.1002/ptr.3207 · Cited by 599
Pathogenesis of alcoholic liver disease: Role of oxidative metabolism
Ceni, E., Mello, T., & Galli, A. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i47.17756 · Cited by 521
Antioxidant Therapy: Current Status and Future Prospects
Firuzi, O., Miri, R., Tavakkoli, M., & Saso, L. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711803414368 · Cited by 468
Metadata
- Authors
- Ramasamy, K., & Agarwal, R.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2008-10
- Volume
- 269
- Issue
- 2
- Pages
- 352-362
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2059726407
- Cited by
- 442
- References
- 56
- FWCI
- 17.53
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.